267 related articles for article (PubMed ID: 32800772)
1. Histone deacetylase 3-selective inhibitor RGFP966 ameliorates impaired glucose tolerance through β-cell protection.
Lei L; Bai G; Wang X; Liu S; Xia J; Wu S; Huan Y; Shen Z
Toxicol Appl Pharmacol; 2020 Nov; 406():115189. PubMed ID: 32800772
[TBL] [Abstract][Full Text] [Related]
2. HDAC3 inhibition prevents blood-brain barrier permeability through Nrf2 activation in type 2 diabetes male mice.
Zhao Q; Zhang F; Yu Z; Guo S; Liu N; Jiang Y; Lo EH; Xu Y; Wang X
J Neuroinflammation; 2019 May; 16(1):103. PubMed ID: 31101061
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1/2 pathway.
Xu Z; Tong Q; Zhang Z; Wang S; Zheng Y; Liu Q; Qian LB; Chen SY; Sun J; Cai L
Clin Sci (Lond); 2017 Aug; 131(15):1841-1857. PubMed ID: 28533215
[TBL] [Abstract][Full Text] [Related]
4. Proteomic Analysis of HDAC3 Selective Inhibitor in the Regulation of Inflammatory Response of Primary Microglia.
Xia M; Zhao Q; Zhang H; Chen Y; Yuan Z; Xu Y; Zhang M
Neural Plast; 2017; 2017():6237351. PubMed ID: 28293439
[TBL] [Abstract][Full Text] [Related]
5. Targeting HDAC3 Activity with RGFP966 Protects Against Retinal Ganglion Cell Nuclear Atrophy and Apoptosis After Optic Nerve Injury.
Schmitt HM; Schlamp CL; Nickells RW
J Ocul Pharmacol Ther; 2018 Apr; 34(3):260-273. PubMed ID: 29211617
[TBL] [Abstract][Full Text] [Related]
6. The HDAC3 inhibitor RGFP966 ameliorated ischemic brain damage by downregulating the AIM2 inflammasome.
Zhang MJ; Zhao QC; Xia MX; Chen J; Chen YT; Cao X; Liu Y; Yuan ZQ; Wang XY; Xu Y
FASEB J; 2020 Jan; 34(1):648-662. PubMed ID: 31914678
[TBL] [Abstract][Full Text] [Related]
7. RGFP966, a selective HDAC3 inhibitor, ameliorates allergic and inflammatory responses in an OVA-induced allergic rhinitis mouse model.
Zhang W; Sun X; Ba G; Tang R; Lin H
Int Immunopharmacol; 2021 Apr; 93():107400. PubMed ID: 33529911
[TBL] [Abstract][Full Text] [Related]
8. HDAC3 inhibitor suppresses endothelial-to-mesenchymal transition via modulating inflammatory response in atherosclerosis.
Chen L; Shang C; Wang B; Wang G; Jin Z; Yao F; Yue Z; Bai L; Wang R; Zhao S; Liu E; Wang W
Biochem Pharmacol; 2021 Oct; 192():114716. PubMed ID: 34339713
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase 3 inhibition improves glycaemia and insulin secretion in obese diabetic rats.
Lundh M; Galbo T; Poulsen SS; Mandrup-Poulsen T
Diabetes Obes Metab; 2015 Jul; 17(7):703-7. PubMed ID: 25846481
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibition by MS-275 potentiates glucose-stimulated insulin secretion without affecting glucose oxidation.
Zhang Y; Li M; Wang Y; Liu X; Zhou L; Zhang C; Shao L
Life Sci; 2020 Sep; 257():118073. PubMed ID: 32663574
[TBL] [Abstract][Full Text] [Related]
11. Conditional ablation of HDAC3 in islet beta cells results in glucose intolerance and enhanced susceptibility to STZ-induced diabetes.
Chen WB; Gao L; Wang J; Wang YG; Dong Z; Zhao J; Mi QS; Zhou L
Oncotarget; 2016 Sep; 7(36):57485-57497. PubMed ID: 27542279
[TBL] [Abstract][Full Text] [Related]
12. HDAC3 inhibitor RGFP966 controls bacterial growth and modulates macrophage signaling during Mycobacterium tuberculosis infection.
Campo M; Heater S; Peterson GJ; Simmons JD; Skerrett SJ; Mayanja-Kizza H; Stein CM; Boom WH; Hawn TR
Tuberculosis (Edinb); 2021 Mar; 127():102062. PubMed ID: 33639591
[TBL] [Abstract][Full Text] [Related]
13. The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington's Disease Mice.
Jia H; Wang Y; Morris CD; Jacques V; Gottesfeld JM; Rusche JR; Thomas EA
PLoS One; 2016; 11(3):e0152498. PubMed ID: 27031333
[TBL] [Abstract][Full Text] [Related]
14. A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis.
Cho JM; Jang HW; Cheon H; Jeong YT; Kim DH; Lim YM; Choi SH; Yang EK; Shin CY; Son MH; Kim SH; Kim HJ; Lee MS
Diabetes Res Clin Pract; 2011 Jan; 91(1):72-9. PubMed ID: 21093089
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of BDNF Expression and Memory by HDAC Inhibition Requires BET Bromodomain Reader Proteins.
Sartor GC; Malvezzi AM; Kumar A; Andrade NS; Wiedner HJ; Vilca SJ; Janczura KJ; Bagheri A; Al-Ali H; Powell SK; Brown PT; Volmar CH; Foster TC; Zeier Z; Wahlestedt C
J Neurosci; 2019 Jan; 39(4):612-626. PubMed ID: 30504275
[TBL] [Abstract][Full Text] [Related]
16. HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity.
Leus NG; van der Wouden PE; van den Bosch T; Hooghiemstra WTR; Ourailidou ME; Kistemaker LE; Bischoff R; Gosens R; Haisma HJ; Dekker FJ
Biochem Pharmacol; 2016 May; 108():58-74. PubMed ID: 26993378
[TBL] [Abstract][Full Text] [Related]
17. Deletion of histone deacetylase 3 in adult beta cells improves glucose tolerance via increased insulin secretion.
Remsberg JR; Ediger BN; Ho WY; Damle M; Li Z; Teng C; Lanzillotta C; Stoffers DA; Lazar MA
Mol Metab; 2017 Jan; 6(1):30-37. PubMed ID: 28123935
[TBL] [Abstract][Full Text] [Related]
18. RGFP966 is protective against lipopolysaccharide-induced depressive-like behaviors in mice by inhibiting neuroinflammation and microglial activation.
Bian HT; Xiao L; Liang L; Xie YP; Wang HL; Wang GH
Int Immunopharmacol; 2021 Dec; 101(Pt B):108259. PubMed ID: 34666303
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase-3 regulates the expression of the amyloid precursor protein and its inhibition promotes neuroregenerative pathways in Alzheimer's disease models.
Davis N; Taylor B; Abelleira-Hervas L; Karimian-Marnani N; Aleksynas R; Syed N; Di Giovanni S; Palmisano I; Sastre M
FASEB J; 2024 May; 38(10):e23659. PubMed ID: 38733301
[TBL] [Abstract][Full Text] [Related]
20. Isoform-selective inhibitor of histone deacetylase 3 (HDAC3) limits pancreatic islet infiltration and protects female nonobese diabetic mice from diabetes.
Dirice E; Ng RWS; Martinez R; Hu J; Wagner FF; Holson EB; Wagner BK; Kulkarni RN
J Biol Chem; 2017 Oct; 292(43):17598-17608. PubMed ID: 28860191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
